Secondary sclerosing cholangitis following major burn injury-An underestimated issue in burn care?
R
R
Ipaktchi
K
K
Knobloch
P M
PM
Vogt
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002056:Burns / Q000150:complications*; D015209:Cholangitis, Sclerosing / Q000188:drug therapy / Q000209:etiology*; D016638:Critical Illness; D006801:Humans; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D014580:Ursodeoxycholic Acid